WNBA announces multi-year partnership with first-ever over-the-counter birth control pill

Fox News Flash top sports headlines are here. Check out what's clicking on Foxnews.com.

The WNBA and the manufacturer of the first-ever over-the-counter birth control pill announced a multi-year partnership on Tuesday — a partnership that will make its debut during the 2024 WNBA Draft on Monday. 

In a joint press release, the WNBA and Perrigo announced the new partnership which focuses on the league’s efforts this season to bring attention to "civic engagement and reproductive health advocacy."

The 2023 WNBA Draft Lottery on November 11, 2022 at ESPN in Bristol, Connecticut.  (Chris Marion/NBAE via Getty Images)

"At the WNBA, we are committed to addressing issues that matter to the players, and expanding access to reproductive healthcare is one of those key issues," WNBA Chief Growth Officer Colie Edison said in a statement.  

CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COM

"It’s great to be working with a partner whose values align and authentically integrates into the health equity work our players are dedicated to."

Just last month, Opill became the first daily oral contraceptive available in the United States without a prescription. 

Opill, a nonprescription birth control drug from Perrigo Co., arranged in Hastings-on-Hudson, New York, US, on Saturday, April 6, 2024. (Tiffany Hagler-Geard/Bloomberg via Getty Images)

WNBA LEGEND'S WARNING FOR CAITLIN CLARK BEFORE TURNING PRO: 'REALITY IS COMING' ’

"Opill is changing the game in reproductive health, just like the WNBA’s game-changing role in sports and pop culture," Leila Bahbah, Perrigo U.S. Women’s Health Brand Lead, said in a statement. "Building upon our shared commitment to foster equitable access and to increase health education, the goal of this